What is CG Oncology's debt-to-assets?

CG Oncology (CGON) reported debt-to-assets of 0× in Q1 2026.

How has CG Oncology's debt-to-assets changed year-over-year?

CG Oncology's debt-to-assets increased by 378.6% year-over-year, from 0× to 0×.

What is the long-term trend for CG Oncology's debt-to-assets?

Over 2 years (2023 to 2025), CG Oncology's debt-to-assets has grown at a 96.7% compound annual growth rate (CAGR), from 0× to 0×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

CG Oncology CGON Debt-to-assets

Debt-to-assets at other companies

PfizerPFE

0.3×0.0×

Johnson & JohnsonJNJ

0.3×0.0×

Gilead SciencesGILD

0.4×0.0×

ImmunityBio, Inc.IBRX

0.7×-0.4×

Cogent Biosciences, Inc.COGT

0×0.0×

Tango TherapeuticsTNGX

0.1×-0.1×

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Enterprise value$5.36B+212%

P/S1,062.4×-1,596×

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Calculated from CG Oncology’s reported figures.

total debt/total assets=0×

Based on the most recent quarter.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's debt-to-assets?: CG Oncology (CGON) reported debt-to-assets of 0× in Q1 2026.
How has CG Oncology's debt-to-assets changed year-over-year?: CG Oncology's debt-to-assets increased by 378.6% year-over-year, from 0× to 0×.
What is the long-term trend for CG Oncology's debt-to-assets?: Over 2 years (2023 to 2025), CG Oncology's debt-to-assets has grown at a 96.7% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.